Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective study.
Harinder GillRita YimHarold K K LeeVivien MakShek-Ying LinBonnie KhoSze-Fai YipJune S M LauWah LiHo-Wan IpYu-Yan HwangThomas S Y ChanEric TseWing-Yan AuCyrus R KumanaYok Lam KwongPublished in: Cancer (2018)
For patients with relapsed APL, As2 O3 remained effective despite repeated As2 O3 exposures. Oral As2 O3 maintenance was an effective postremission strategy for CR2. Cancer 2018;124:2316-26. © 2018 American Cancer Society.